ClinicalTrials.gov
public full text
Public Domain
Potential Benefits of Expanded Hemodialysis in Prevention of Sarcopenia
The current study will investigate whether long term implementation of expanded hemodialysis (HDx) will effectively decrease serum levels of large uremic toxins and ameliorate progression of sarcopenia in patients with chronic kidney disease requiring hemodialysis.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- FGF19 and Chronic Kidney Disease#837956
- Prevalence and Determinants of Sarcopenic Obesity in Taiwanese Dialysis Patients#900758
- Effects of Sarcopenia and Frailty on Cognitive Function, Brain Volume, and Dementia Risk: A Prospective Cohort Study Based on UK Biobank.#154368
- Study of the Impact of HYPOglycaemia on Sarcopenia in CIRrhosis#1198604
- Effect of Exercise and Protein Supplementation on Muscle Function in Patients With Hemodialysis#838171
Record · ID 1184918
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive